Trust Stamp Selected for ICBA ThinkTECH Accelerator
ATLANTA, Dec. 08, 2023 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity CompanyTM, announced today its selection to the Independent Community Bankers of America’s (ICBA) ThinkTECH Accelerator program,
The SGO.CC Enters African Market, Investing $2.2 Million to Develop football Stars, Boost Football Industry, and Expand Platform Influence
Denver, Colorado, Dec. 08, 2023 (GLOBE NEWSWIRE) — According to company news,SGO.CC is planning to invest $2.2 million in the African market from the end of 2023 to June 2024,
Norton Healthcare, Inc. Experiences Ransomware Attack
LOUISVILLE, Ky., Dec. 08, 2023 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASE On May 9, 2023, Norton Healthcare, Inc. (“Norton Healthcare”), a not for profit health system with eight hospitals in
AAHA Announces Enhanced Digital Benchmarking Platform – Now Free for All Members
Lakewood, CO, Dec. 08, 2023 (GLOBE NEWSWIRE) — The American Animal Hospital Association (AAHA) is proud to partner with Chewy Health to provide its comprehensive analytics platform, AAHA Benchmarking+, free
Masa Depan Hartanah Mewah Kian Global! eXp Luxury Dilancarkan di Australia, New Zealand, South Africa dan United Kingdom
BELLINGHAM, Wash., Dec. 09, 2023 (GLOBE NEWSWIRE) — eXp Realty, “the most agent-centric real estate brokerage on the planet™” dan anak syarikat teras eXp World Holdings, Inc. (Nasdaq: EXPI), dengan
Fleet Science Center Supports Girls Building STEM Identities
San Diego, CA, United States, Dec. 08, 2023 (GLOBE NEWSWIRE) — In its ongoing commitment to foster development of science, technology, engineering and math (STEM) identities in girls and nonbinary
Study Finds Opto-Acoustic Imaging During Neoadjuvant Therapy Correlates to Pathologic Response
San Antonio, Texas, Dec. 08, 2023 (GLOBE NEWSWIRE) — A limited feasibility study presented at this year’s San Antonio Breast Cancer Symposium (SABCS) found that Seno Medical’s Imagio® Breast Imaging
End of Day Message
LONDON, 08 Dec. 2023 (GLOBE NEWSWIRE) — This is the End of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved
Mobiv Acquisition Corp Announces Closing of Business Combination with SRIVARU Holding Limited
Newark, Delaware, Dec. 08, 2023 (GLOBE NEWSWIRE) — Mobiv Acquisition Corp (Nasdaq: MOBVU, MOBV, MOBVW) (the “Company” or “Mobiv”) announced that on December 8, 2023, the Company consummated the previously
New Simple Invention by Coates International, Ltd. that Could Counteract Global Warming and Help Save the Planet
THE COATES CHARCOAL AMBIENT AIR CLEANING SYSTEM Wall Township, NJ, Dec. 08, 2023 (GLOBE NEWSWIRE) — Air is a combination of different gases. Our earth’s atmosphere consists of approximately 78%
Questex’s Fierce Telecom Announce the 2023 Fierce Innovation Awards — Telecom Edition Finalists
NEW YORK, Dec. 08, 2023 (GLOBE NEWSWIRE) — Questex’s Fierce Telecom and Fierce Wireless today announces the 2023 Fierce Innovation Awards — Telecom Edition finalists. The awards recognize the creators,
Self Storage Development Achieves Net Zero Carbon Certification, the First of Its Kind in Canada
Vancouver, BC, Dec. 08, 2023 (GLOBE NEWSWIRE) — Advanced Self Storage, in partnership with the Nicola Wealth Real Estate (NWRE) team, is proud to announce their Maple Meadows project, a
Simply Healthcare Plans Awards $85,000 Grant to Pace Center for Girls to Combat Youth Mental Health Crisis
Jacksonville, Fl., Dec. 08, 2023 (GLOBE NEWSWIRE) — Pace Center for Girls (Pace) received a $85,000 grant from Simply Healthcare Plans (Simply) to support Pace’s Reach Therapy model, a community-based
Readout of SBA Administrator Guzman’s Attendance at the 2023 White House Tribal Nations Summit at White House
WASHINGTON, Dec. 08, 2023 (GLOBE NEWSWIRE) — On Thursday, December 7, Administrator Isabel Casillas Guzman, head of the U.S. Small Business Administration (SBA) and the voice in President Biden’s cabinet for America’s
Roche’s Kadcyla is the first targeted therapy to show significant overall survival benefit in people with HER2-positive early-stage breast cancer with residual invasive disease after neoadjuvant treatment
Phase III KATHERINE results reinforce Kadcyla as the standard of care for this population, with more than 82,000 people treated to date1,2 Long-term data also showed continued benefit in invasive